Barclays announced expanded coverage on seven biotech stocks Wednesday. Below are the new ratings and price targets along with comments from analyst Geoff Meacham.Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) was rated at Underweight with an $8 price target. The firm’s thesis was that “Achillion is likely to get left behind even with solid clinical data; a takeout may be one of […]
View photo.By and large, short interest among the leading biotechs and emerging pharmaceuticals reversed course and rose again between the January 30 and February 13 settlement dates.Leading that trend were Amgen, Inc. (NASDAQ: AMGN), Juno Therapeutics Inc (NASDAQ: JUNO) and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX).Below we take a quick look at how these three stocks have fared recently and what […]
In a report published Tuesday, JMP Securities named three biotech stocks it is watching: Acceleron Pharma Inc (NASDAQ: XLRN), Cardiovascular Systems Inc (NASDAQ: CSII) and Karyopharm Therapeutics Inc (NASDAQ: KPTI).Acceleron’s (Market Outperform, $52 price target) early stage clinical results at ASCO Genitourinary(GU) 2015 “support a positive outlook for maturing PFS results while providing encouragement for ongoing later stage development.”According to analyst Michael […]
The Seven Financial Indicators of Highly Successful Biotech Stocks InvestingCompanies / BioTechFeb 21, 2015 – 10:41 AM GMTBy: Money_MorningErnie Tremblay writes: When evaluating biotech stocks, many key indicators that work for other industries – e.g. price-to-earnings ratio, profit margin, revenue-per-share – often don’t apply.Here’s why they don’t, and why seven of these critical financial indicators do…The Usual Ratios Don’t ApplyThe […]
View photo.Biotech stocks have performed well in the recent bull market.Since January 1, 2008, the SPDR S&P Biotech ETF (NYSE: XBI) has outperformed the SPDR S&P 500 ETF Trust (NYSE: SPY), gaining 233 percent compared with just 41.3 percent gains in SPY.Analysts at Sterne Agee took a closer look at three active biotech companies in separate notes Friday morning.Molina Healthcare, […]
Benchmarks ended Wednesday’s choppy session almost unchanged as uncertainty regarding bailout negotiations between Greece and its creditors dented investor sentiment. Moreover, renewed worries about the Russia-Ukraine crisis also dampened investor sentiment. Meanwhile, another decline in oil prices following rise in crude inventories dragged down energy shares. However, encouraging earnings results including those from Pepsico and Mondelez limited losses yesterday.For a […]
Some well-known biotechnology exchange traded funds could be stirred by Gilead Sciences (GILD) fourth-quarter earnings report released Tuesday after the close of U.S. markets.The California-based company posted net income of $3.49 billion, or $2.18 a share, compared with $791 million, or 47 cents a share, a year earlier as revenue more than doubled to $7.31 billion from $3.12 billion on […]
NEW YORK (MarketWatch) — The U.S. stocks were under pressure on Wednesday as crude-oil prices gave up part of the gains racked up over a four-day trading span, while a report on private-sector hiring disappointed.Private employers added 213,000 jobs in January, according Automatic Data Processing Inc. Economists use the number to get a feel for the official jobs report due […]
Jay Yarow
Jan. 28, 2015, 7:39 AM
7,149
Smithsonian/Renegade PicturesSee Also15 Mind-Blowing Facts About Apple’s Latest QuarterApple Has Shipped 1 Billion iOS DevicesApple Crushes EarningsAfter digesting Apple’s historic earnings report, investors have decided to buy more Apple stock.Apple is up 9% in premarket trading. It was up by only 5% after-hours Tuesday night, so investors have clearly gotten more excited about Apple’s potential.Apple […]
It’s silly time in the stock market calendar. First there was the Santa Claus rally in December, then there is the incessant talk about the January Effect, then it’s the Super Bowl Indicator, then it will be “sell in May” and on and on. I am sorry to sound harsh, but these indicators are less than useless. They are little […]
